Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy
Dal Monte M;Cammalleri M;Pecci V;Carmosino M;Procino G;Pini A;De Rosa M;Pavone V;Svelto M;Bagnoli P;;
Journal of cellular and molecular medicine2019Vol. 23pp. -
554
m2019journalinhibiting
Abstract
The urokinase-type plasminogen activator (uPA) receptor (uPAR) participates to the mechanisms causing renal damage in response to hyperglycaemia. The main function of uPAR in podocytes (as well as soluble uPAR -(s)uPAR- from circulation) is to regulate podocyte function through αvβ3 integrin/Rac-1. …